ResMed Inc. (NYSE:RMD) Q4 2023 Earnings Call Transcript

Page 11 of 11

And as a personal user of these products, I try every new mask that comes out and this new one, which has a great project name that I’m not able to say, but it’s a beautiful island that you can travel to by boats. I have tried that that mask and it’s incredible and I can’t wait for that to come to the market. But yes, look, we do have masks that are coming in the pipeline that are working their way through regulatory and then of course, commercial ramp up to make sure that when we deliver, it’s ResMed quality, ResMed capability, first time fit, incredible adherence, and to drive through the channel. And so you’ll see those come through our major markets and then globally throughout the fiscal year. So I’m excited about that pipeline. The one that I can talk about is the digital side, where we’ve launched an AI product and I’m really excited as those get more traction, we’ll talk about how the digital products and the mass products throughout the year are going to impact and keep our incredibly strong double-digit growth that we saw this quarter.

Operator: Thank you. We’ve reached the end of our question-and-answer session. I’d like to turn the floor back over to Mick for any further or closing comments.

Mick Farrell: Yes. Thanks, Kevin. And thanks to all of our stakeholders for joining us this last hour as we talked through our results. And we’ll talk to you again in 90 days. In closing, I want to thank the 10,000 ResMedians. Many of you are shareholders and listen to these calls as well, thanks for your dedication and hard work, helping people sleep better, breathe better, live better lives in 140 countries. These results are yours, incredible double-digit growth. Thanks for all that you do. I’ll hand the call back to you Amy to close this out.

Amy Wakeham: Awesome. Thank you, Mick, and thanks, everyone. We do appreciate your interest and your time. If you have any additional questions, please don’t hesitate to reach out directly. This does conclude our ResMed’s fourth quarter 2023 conference call. Kevin, I’ll turn it back to you to close the call.

Operator: Thank you. You may now disconnect. We do thank you for your participation today.

Follow Resmed Inc (NYSE:RMD)

Page 11 of 11